Invesaro

Stocks PNXP Financial statements

Financial statements

PINEAPPLE EXPRESS CANNABIS Co financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data PINEAPPLE EXPRESS CANNABIS Co files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2019FY2020FY2021FY2021FY2023FY2024FY2025
Revenue0.010.040.030.010.0100.02
Cost of revenue00.010.01
Gross profit0.010.030.020.010.01
General and administrative-0.02-0.040.040.050.020.060.02
Operating expenses-0.02-0.040.040.050.020.060.03
Operating income-00.02-0.05-0.02-0.06-0.02
Other non-operating income-0.03
Pre-tax income-0.04-0.06-0.03
Income tax00
Income from continuing operations0.020.05
Net income-0-0-0.02-0.05-0.04-0.06-0.03
EBITDA-00.03-0.03-0.01-0.06
EPS, basic0.000.000.000.000.00-0.010.00
EPS, diluted0.000.000.000.000.000.010.00
Shares, basic (weighted)3.731920.319.8
Shares, diluted (weighted)2.82.843.053.731920.319.8
Dividend per share30.00

Balance sheet

FY2019FY2020FY2021FY2021FY2023FY2024FY2025
Cash and equivalents0000.01000
Other current assets00.020
Total current assets00.020.010.01000
Property, plant and equipment00.010.030.01000
Long-term investments0-0.01-0.01
Total assets00.030.030.02000
Accounts payable00000.020
Accrued liabilities0.010.020.04
Deferred revenue0
Total current liabilities0.010.040.050.080.550.020
Total liabilities00.030.050.080.550.020
Paid-in capital000.010.020.020.610.65
Retained earnings-0.01-0.010.03-0.08-0.58-0.64-0.67
Shareholders' equity-0.01-0.01-0.02-0.06-0.54-0.02
Total equity-0.01-0.01-0.02-0.06-0.54-0.02-0
Total liabilities and equity-0.01-0.010.030.02000
Shares outstanding2.832.953.583.731919

Cash flow statement

FY2019FY2020FY2021FY2021FY2023FY2024FY2025
Net income-0-0-0.02-0.05-0.04-0.06-0.03
Depreciation and amortization000.020.0100
Stock-based compensation0
Change in receivables0-0.01
Change in payables0-000-00.02-0.03
Cash from operations-0-0.01-0-0.03-0.020-0.05
Capital expenditures-0-0.01
Acquisitions-0
Purchases of investments-0.010
Cash from investing-0-0.010.03
Stock issued0.01000.05
Share buybacks-0-0
Cash from financing00.020.030.030.0100.05
Net change in cash00-0.010-0
Free cash flow-0.01-0.01
Interest paid00000
Income taxes paid00000

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to October 31, 2025; growth uses fiscal years. Valuation uses the share price of $0.00 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Return on assets (ROA)-343.6%Net income / average total assets.

Growth

MetricValueHow it is calculated
Revenue CAGR, 3y27.8%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y-17.7%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y-100.0%EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y-150,203.0%Operating cash flow vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y-100.0%Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y-2.3%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y74.5%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y47.5%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.00xCurrent assets / current liabilities.
Quick ratio0.00x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.00x(Cash + short-term investments) / current liabilities.
Liabilities / assets4,392.0%Total liabilities / total assets.
Working capital-$8.3MCurrent assets - current liabilities.

Efficiency

MetricValueHow it is calculated
Asset turnover0.00xRevenue / average total assets.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.02Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$0.00Revenue / diluted weighted shares.
Operating cash flow per share$0.02Cash from operations / diluted weighted shares.
Cash per share$0.00(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$34.1KShare price x shares outstanding.
Enterprise value$34.1KMarket cap + total debt - cash - short-term investments.
P/OCF0.04xMarket cap / cash from operations, when positive.
Earnings yield-1,915.0%Net income / market cap (the inverse of P/E).
What was PINEAPPLE EXPRESS CANNABIS Co's revenue in fiscal 2025?

PINEAPPLE EXPRESS CANNABIS Co reported revenue of $16.2K for fiscal 2025.

Was PINEAPPLE EXPRESS CANNABIS Co profitable in fiscal 2025?

No. It reported a net loss of $31.2K.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to PINEAPPLE EXPRESS CANNABIS Co